Iris Dorbian

Iris Dorbian

NeuroPharma nabs $36 mln Series C

Seattle-based Impel NeuroPharma Inc, which is focused on developing treatments for central nervous disorders, has secured $36 million in Series C funding round. The investors were venBIO, 5AM Ventures and Vivo Capital.

1 min read · 05 December 2016

MoneyLion grabs $22.5 mln Series A

Edison Partners has led a $22.5 million Series A funding round for MoneyLion, a personal finance platform. No financial terms were disclosed. Other investors that participated in the round included FinTech Collective, Citizen.VC, Clocktower Ventures, Broadhaven Capital Partners and Montage Ventures.

3 min read · 05 December 2016

Therillia appoints chief business officer

Montreal-based drug developer Therillia Development Company Inc has hired Dr. Pierre Beauparlant as chief business officer. Previously, he worked at Novartis Pharmaceuticals Canada where he was medical therapeutic head of hematology. Therillia is backed by Sanderling Ventures, an investment firm focused on new biomedical companies.

3 min read · 05 December 2016

Ad tech startup GuaranteedPROS to bag $2 mln seed from Panamax

GuaranteedPROS Inc will secure $2 million in seed funding from Panamax Capital LLC. Based in South Florida, GuaranteedPROS is an ad tech startup.

3 min read · 05 December 2016

NEA leads Series C round for Datrium

Sunnyvale, California-based Datrium, an open convergence platform for cloud builders, has raised $55 million in Series C financing. New Enterprise Associates led the round with participation from return backer Lightspeed Venture Partners.

1 min read · 05 December 2016

CIIX teams up with Chinese PE fund Yuanrong to back U.S. cannabis industry

ChineseInvestors.com, a financial info site for Chinese investors, has inked a partnership deal with Shenzhen Yuanrong PE Capital, a Chinese private equity fund. According to terms of the agreement, both CIIX and Yuanrong will raise seed capital from mainland Chinese investors to invest in the U.S. cannabis sector.

3 min read · 05 December 2016

Emergence Capital adds Landis as growth partner

Emergence Capital has named Doug Landis as a growth partner. Previously, he worked at Box where he served as vice president of sales productivity. And prior to that, he led corporate sales productivity at Salesforce and was a sales training manager at Google.

2 min read · 05 December 2016

OrthoSpace scores $7 mln

Israel-based OrthoSpace Ltd, a shoulder implant company, has raised $7 million in funding. The investors were HealthpointCapital LLC, Smith & Nephew, TriVentures and Johnson & Johnson Innovation - JJDC Inc.

1 min read · 02 December 2016

Quark Venture backs SQZ Biotech

SQZ Biotech, which is developing cell therapies to harness the body’s immune system and combat disease, has secured $4 million in funding. The investor is Vancouver-based venture firm Quark Venture Inc. As a result of this investment, SQZ's total funding is now $24 million

1 min read · 02 December 2016

Founder Collective wraps up third fund at $75 mln

Founder Collective has hit its $75 million target for its third fund, according to an SEC filing. Based in Cambridge, Massachusetts, the seed-stage venture firm backs a diversity of sectors that include ecommerce, healthcare, advertising, mobile and internet of things.

1 min read · 01 December 2016

Showing 3,651 to 3,660 of 7,132 results
1…365367…714